Skip to search formSkip to main contentSkip to account menu

rimonabant

Known as: 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide, N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Action potentials trigger synaptic terminals to synchronously release vesicles, but some vesicles release spontaneously. G… 
Highly Cited
2009
Highly Cited
2009
AIMS Because smoking cessation rates might be improved by combining drugs and by reducing post-cessation weight gain, we tested… 
Highly Cited
2009
Highly Cited
2009
Type 2 diabetes and obesity are characterized by elevated nocturnal circulating free fatty acids, elevated basal insulin… 
Highly Cited
2008
Highly Cited
2008
We investigated the effect of rimonabant on inflammation and enhanced platelet reactivity in type 2 diabetic Zucker rats, an… 
Highly Cited
2007
Highly Cited
2007
A high-performance liquid chromatography (HPLC) method using a fused-core silica particle packing was evaluated to allow fast and… 
2007
2007
The observations that the cannabinoid1(CB1) receptor antagonist/inverse agonist, rimonabant, and the selective noncompetitive…